Effectiveness of prophylactic antimicrobial levofloxacin against postureteroscopic lithotripsy infection: A multicenter prospective open-label randomized controlled trial
Open Access
- 7 April 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (14) , e33364
Abstract
Background: To verify the appropriate prophylactic agent to prevent ureteroscopic lithotripsy infection, which is safe, effective, convenient, reasonable, and with best pharmacoeconomic benefit ratio, to provide evidence for clinical practice. Methods: This study is a multicenter, open-label, randomized, positive drug-controlled trial design. From January 2019 to December 2021, patients with ureteral calculi who were going to undergo retrograde flexible ureteroscopic lithotripsy were selected from urology departments in 5 research centers. The patients enrolled were randomly divided into the experimental group and the control group according to the random number table by blocking randomization. In the experimental group (Group A), 0.5 g levofloxacin was given 2 to 4 hours before surgery. In the control group (Group B), cephalosporin was injected 30 minutes before surgery. The infectious complications, the incidence of adverse drug reactions and the economic benefit ratio were compared between the 2 groups. Results: A total of 234 cases were enrolled. There was no statistically significant difference between the 2 groups at baseline. Postoperative infection complications were 1.8% in the experimental group, which was significantly lower than 11.2% in control group. The type of infection complication in both groups was asymptomatic bacteriuria. The cost of drugs in the experimental group was 19.89 ± 13.11 yuan, which was significantly lower than cost of drugs in the control group of 41.75 ± 30.12 yuan. The levofloxacin application had favorable cost-effectiveness ratio. The difference in safety between 2 groups was not significant. Conclusion: The application of levofloxacin is safe, effective, and low-cost regimen for postureteroscopic lithotripsy infection prevention.Keywords
This publication has 14 references indexed in Scilit:
- Antibiotic use and the prevention and management of infectious complications in stone diseaseWorld Journal of Urology, 2017
- The “Guidewire-Coil”-Technique to prevent retrograde stone migration of ureteric calculi during intracorporeal lithothripsyBMC Urology, 2017
- Postoperative Infection Rates in Patients with a Negative Baseline Urine Culture Undergoing Ureteroscopic Stone Removal: A Matched Case–Control Analysis on Antibiotic Prophylaxis from the CROES URS Global StudyJournal of Endourology, 2015
- Flexible ureterorenoscopy versus semirigid ureteroscopy for the treatment of proximal ureteral stones: a retrospective comparative analysis of 124 patients.2014
- In vitro susceptibility of Escherichia colistrains isolated from urine samples obtained in mainland China to fosfomycin trometamol and other antibiotics: a 9-year surveillance study (2004–2012)BMC Infectious Diseases, 2014
- Best Practice Policy Statement on Urologic Surgery Antimicrobial ProphylaxisJournal of Urology, 2008
- Prevalence of urolithiasis in the autonomous city of Buenos Aires, ArgentinaUrological Research, 2006
- Perioperative Antibiotic Prophylaxis in Ureteroscopic Stone RemovalEuropean Urology, 2003
- [Urolithiasis prevalence and risk factors in Yucatan, Mexico].2002
- Prevalencia y factores de riesgo en Yucatán, México, para litiasis urinariaSalud Pública de México, 2002